You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Epstein-Barr Virus

Showing 1 - 25 of 6,913
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial in Boston (Truvada (tenofovir/emtricitabine))

Enrolling by invitation
  • Multiple Sclerosis
  • Truvada (tenofovir/emtricitabine)
  • Boston, Massachusetts
    Massachusetts General Hospital
Jul 14, 2023

Epstein Barr Virus Infection in Radiologically Isolated Syndrome

Recruiting
  • Multiple Sclerosis
  • +2 more
  • NO INTERVENTION
  • Nice, France
    Nice University Hospital
Apr 3, 2023

Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

Recruiting
  • Secondary Hemophagocytic Lymphohistiocytosis
  • Chronic Active Epstein-Barr Virus Infection
  • No intervention
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
May 2, 2023

Early Detection of Epstein-Barr Virus Related Disease.

Active, not recruiting
  • Post-transplant Lymphoproliferative Disorder
  • +8 more
    • Aarhus, Central Region Of Denmark, Denmark
      Aarhus University Hospital
    Dec 12, 2022

    PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)

    Not yet recruiting
    • PD-1 Antibody
    • +3 more
    • L-DEP and PD-1 antibody
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Mar 8, 2023

    Genetic Studies of Chronic Active Epstein-Barr Disease

    Recruiting
    • Chronic Active Epstein-Barr Virus
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Epstein-Barr Virus Infections, Lymphoma, Lymphoproliferative Disorder Trial run by the NCI (Nivolumab)

      Recruiting
      • Epstein-Barr Virus Infections
      • +3 more
      • Nivolumab
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 24, 2023

      Study on Infectious Mononucleosis in Munich

      Completed
      • Infectious Mononucleosis
      • Epstein-Barr Virus Infections
        • Munich, Bavaria, Germany
          MRI Chonic Fatigue Center for Young People (MCFC), Children's Ho
        Aug 16, 2023

        Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma Trial

        Not yet recruiting
        • Adenocarcinoma of the Stomach
        • +2 more
        • Hangzhou, Zhejiang, China
        • +7 more
        Jul 25, 2023

        Segmental Resection Combined With DEP Regimen for EBV-HLH

        Not yet recruiting
        • Hemophagocytic Lymphohistiocytosis
        • +2 more
        • Segmental bowel resection combined with the DEP regimen
        • Beijing, Beijing, China
          Zhao Wang
        Nov 9, 2023

        Epstein-Barr Virus Infection, Infectious Mononucleosis, Herpesvirus Trial run by the National Institute of Allergy and

        Not yet recruiting
        • Epstein-Barr Virus Infection
        • +2 more
        • Matrix-M1 Adjuvant
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 2, 2023

        Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)

        Not yet recruiting
        • Adenovirus
        • +2 more
        • Specific T- Lymphocytes
        • Pittsburgh, Pennsylvania
          UPMC Children's Hospital of Pittsburgh
        Sep 8, 2023

        Epstein-Barr Virus Infection moniToring in renAl Transplant

        Recruiting
        • EBV Infection
        • +3 more
        • EBV DNA in whole blood and plasma
        • Aarhus, Central Region Denmark, Denmark
        • +2 more
        Dec 12, 2022

        Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for

        Recruiting
        • Nasopharyngeal Carcinoma
        • EBV antibodies test
        • EBV DNA test
        • Guangzhou, Guangdong, China
          Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
        Jul 6, 2022

        Secondary Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection Trial in Beijing (Rituximab

        Recruiting
        • Secondary Hemophagocytic Lymphohistiocytosis
        • Chronic Active Epstein-Barr Virus Infection
        • Rituximab Monotherapy
        • Beijing, China
          Zhao Wang
        May 18, 2022

        CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)

        Not yet recruiting
        • CMV Infection
        • +2 more
        • Virus specific T cells
        • (no location specified)
        Oct 4, 2023

        Immunodeficiency for Severe Epstein-Barr Virus Infection

        Recruiting
        • Epstein-Barr Virus Infections
        • Immunodeficiency
          • Shanghai, Shanghai, China
            Children's Hospital of Fudan University
          Mar 21, 2022

          Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)

          Active, not recruiting
          • Acute Lymphocytic Leukemia
          • Lymphoma
          • Biological/Genetically Modified T cells
          • Cyclophosphamide-based chemotherapy
          • New York, New York
            Memorial Sloan Kettering Cancer Center
          Jan 3, 2023

          ME/CFS, SARS CoV 2 Infection, Fatigue Syndrome, Chronic Trial in München

          Recruiting
          • ME/CFS
          • +3 more
            • München, Germany
              München Klinik Schwabing
            Mar 20, 2023

            Verification of Harmonization of Plasma Epstein-Barr Virus DNA

            Recruiting
            • Nasopharyngeal Carcinoma
            • Plasma EBV DNA qPCR test
            • Guangzhou, Guangdong, China
              Sun Yat-sen University Cancer Center
            Jul 3, 2022

            Epstein-Barr Virus Positive, Gastric Adenocarcinoma, Mismatch Repair Protein Deficiency Trial in New Brunswick (drug, other,

            Recruiting
            • Epstein-Barr Virus Positive
            • +10 more
            • Atlanta, Georgia
            • +2 more
            Dec 10, 2022

            Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Singapore (FDG-PET, Galium-68 DOTATATE)

            Recruiting
            • Nasopharyngeal Cancer
            • Epstein-Barr Virus Related Carcinoma
            • FDG-PET
            • Galium-68 DOTATATE
            • Singapore, Singapore
              National Cancer Centre Singapore
            Oct 13, 2022

            EBV, Epstein-Barr Virus Infection, Infectious Mononucleosis Trial run by the NIAID (EBV gp350-Ferritin Vaccine, Matrix-M1)

            Recruiting
            • EBV
            • +2 more
            • EBV gp350-Ferritin Vaccine
            • Matrix-M1
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jul 11, 2022

            EBV Infection Trial in Belgium (2LEBV® / 2LXFS®, Placebo)

            Recruiting
            • EBV Infection
            • 2LEBV® / 2LXFS®
            • Placebo
            • Aartselaar, Belgium
            • +12 more
            Dec 22, 2022

            Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma Trial (tabelecleucel)

            Available
            • Epstein-Barr Virus (EBV) Infections
            • +11 more
            • tabelecleucel
            • (no location specified)
            Feb 15, 2022